TipRanks
Go Ultimate55% OFF

NewAmsterdam Pharma Company (NAMS) Balance Sheet

NewAmsterdam Pharma Company Balance Sheet

NewAmsterdam Pharma Company's total assets for Q2 2026 were $704.45M, a decrease of 3.85% from the previous quarter. NAMS total liabilities were $73.03M for the fiscal quarter, a 8.32% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Mar 23Dec 21
$ 769.28M$ 864.62M$ 347.10M$ 478.50M$ 67.99M
$ 85.85M$ 107.12M$ 58.70M$ 48.43M$ 11.36M
$ 683.43M$ 757.50M$ 288.39M$ 430.07M$ 56.63M

Currency in USD

NewAmsterdam Pharma Company Debt to Assets

0400M800M1.2B8 %12 %16 %20 %LiabilitiesDebt to Assets202020212022202320242025AssetsLiabilitiesDebt to Assets